{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:06:18Z","timestamp":1789761978699,"version":"4.0.1"},"reference-count":4,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.urolonc.2026.08.001","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:11:42Z","timestamp":1789758702000},"page":"725-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u201cReal-world treatment patterns, recurrence, and overall survival of patients with muscle-invasive bladder cancer undergoing radical cystectomy in U.S. oncology practice\u201d"],"prefix":"10.1016","volume":"44","author":[{"given":"Meiwei","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-9664","authenticated-orcid":false,"given":"Panfeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.08.001_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2025.12.018","article-title":"Real-world treatment patterns, recurrence, and overall survival of patients with muscle-invasive bladder cancer undergoing radical cystectomy in U.S. oncology practice","volume":"44","author":"Squires","year":"2026","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.08.001_bib0002","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/aje\/kwad135","article-title":"Immortal time bias with time-varying exposures in environmental epidemiology: a case study in lung cancer survival","volume":"192","author":"Sheridan","year":"2023","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2026.08.001_bib0003","doi-asserted-by":"crossref","first-page":"61.e1","DOI":"10.1016\/j.urolonc.2024.08.001","article-title":"Radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer: analysis of an other-cause mortality matched cohort","volume":"43","author":"Finati","year":"2025","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.08.001_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/bimj.70017","article-title":"Oncology clinical trial design planning based on a multistate model that jointly models progression-free and overall survival endpoints","volume":"67","author":"Erdmann","year":"2025","journal-title":"Biom J"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:20:44Z","timestamp":1789759244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926006927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":4,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1078143926006927"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.08.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on \u201cReal-world treatment patterns, recurrence, and overall survival of patients with muscle-invasive bladder cancer undergoing radical cystectomy in U.S. oncology practice\u201d","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}